{
  "CurrentPageLength": 1,
  "CurrentStartItemIndex": 0,
  "Items": [
    {
      "Id": "research-33_60ddc26b-276b-4606-b036-771c8a214395",
      "ContentId": "33_60ddc26b-276b-4606-b036-771c8a214395",
      "Headline": "Trinity Delta Lighthouse: MaxCyte",
      "Synopsis": "Trinity Delta view: MaxCyte is approaching a landmark with the first regulatory filings for a programme under an SPL. We anticipate a first regulatory decision by year-end 2023 at the earliest. If approved, and pending payor/reimbursement discussions, the first launch of an SPL asset could occur in 2024. Exa-cel approval would have a major impact on MaxCyte’s FY24 revenues given that milestones for BLA/MAA approval are understood to typically be mid-seven figures (potentially per major region), with future revenues also benefiting from post-commercial income. Investment in in-house manufacturing scale up for near-to-mid-term commercialisation of partner products is supported by MaxCyte’s end-June 2022 cash balance of $240.9m. With a robust core cell therapy business and an advancing and growing SPL pipeline, we continue to view MaxCyte as a unique and diversified play on the whole cell engineering field, providing broad exposure across cell types, technologies, indications, and approaches. Our valuation is £980m ($1.27bn) or 964p/$12.53 per share.",
      "ProviderName": "Trinity Delta",
      "Url": "https://www.research-tree.com/research/referral/trinity-delta/trinity-delta-lighthouse-maxcyte/33_60ddc26b-276b-4606-b036-771c8a214395?partner=llms",
      "ThumbnailUrl": "https://rtfilesprod.blob.core.windows.net/publicimages/b579ca8e-bcca-466a-9b40-4c340fdc48b0-financial-ticker-board-1-21x6_m.jpg",
      "ProviderLogoUrl": "https://rtfilesprod.blob.core.windows.net/logos/trinity delta logo.png",
      "ContentType": "Research",
      "SubType": null,
      "Companies": [
        {
          "CompanyName": "CRISPR Therapeutics AG",
          "CompanyUrl": "https://www.research-tree.com/companies/usa/health/crispr-therapeutics-ag/CRSP/NYSE",
          "CurrentPrice": 0.0,
          "CustomSectors": [],
          "Id": "1b8b29cc-4ba8-4d27-8462-ceb35970771b",
          "InternalId": "097c5587-3c78-4f31-8f52-c3b7815e3197",
          "Isin": "CH0334081137",
          "LastDateContentWasAdded": "0001-01-01T00:00:00",
          "LastDateContentWasChanged": "0001-01-01T00:00:00",
          "LastDateContentWasRemoved": "0001-01-01T00:00:00",
          "LatestRating": null,
          "LatestRatingDate": "0001-01-01T00:00:00",
          "Location": "Not Set",
          "MarketCap": 0.0,
          "PriceChg": 0.0,
          "PriceChgPercent": 0.0,
          "Sector": "Biotechnology",
          "Ticker": "CRSP:NYSE",
          "TIDM": "CRSP",
          "BBTicker": "CRSP",
          "AltTicker": "CRSP",
          "AltExchange": "US",
          "Exchange": "NYSE",
          "TotalBlogCount": 0,
          "TotalEventCount": 0,
          "TotalMediaCount": 0,
          "TotalResearchCount": 1,
          "TotalRnsCount": 0
        },
        {
          "CompanyName": "VERTEX PHARMACEUTICALS",
          "CompanyUrl": "https://www.research-tree.com/companies/usa/health/vertex-pharmaceuticals/VRTX/NYSE",
          "CurrentPrice": 0.0,
          "CustomSectors": [],
          "Id": "20811406-763e-401c-9ef6-6b4db8e8b02d",
          "InternalId": "ae96d9aa-f431-4156-b21b-41cd2e367792",
          "Isin": "US92532F1003",
          "LastDateContentWasAdded": "0001-01-01T00:00:00",
          "LastDateContentWasChanged": "0001-01-01T00:00:00",
          "LastDateContentWasRemoved": "0001-01-01T00:00:00",
          "LatestRating": null,
          "LatestRatingDate": "0001-01-01T00:00:00",
          "Location": "Not Set",
          "MarketCap": 0.0,
          "PriceChg": 0.0,
          "PriceChgPercent": 0.0,
          "Sector": "Biotechnology",
          "Ticker": "VRTX:NYSE",
          "TIDM": "VRTX",
          "BBTicker": "VRTX",
          "AltTicker": "VRTX",
          "AltExchange": "US",
          "Exchange": "NYSE",
          "TotalBlogCount": 0,
          "TotalEventCount": 0,
          "TotalMediaCount": 0,
          "TotalResearchCount": 2,
          "TotalRnsCount": 0
        },
        {
          "CompanyName": "Vertex Pharmaceuticals Incorporated",
          "CompanyUrl": "https://www.research-tree.com/companies/usa/health/vertex-pharmaceuticals-incorporated/VRTX/NAS",
          "CurrentPrice": 0.0,
          "CustomSectors": [],
          "Id": "FFQNC3-R",
          "InternalId": "1c330546-dd3b-406e-aea8-bd46e79c9fc5",
          "Isin": "FFQNC3-R    ",
          "LastDateContentWasAdded": "0001-01-01T00:00:00",
          "LastDateContentWasChanged": "0001-01-01T00:00:00",
          "LastDateContentWasRemoved": "0001-01-01T00:00:00",
          "LatestRating": null,
          "LatestRatingDate": "0001-01-01T00:00:00",
          "Location": "Not Set",
          "MarketCap": 0.0,
          "PriceChg": 0.0,
          "PriceChgPercent": 0.0,
          "Sector": "Pharmaceuticals",
          "Ticker": "VRTX:NAS",
          "TIDM": "VRTX",
          "BBTicker": "VRTX",
          "AltTicker": "VRTX",
          "AltExchange": "US",
          "Exchange": "NAS",
          "TotalBlogCount": 0,
          "TotalEventCount": 0,
          "TotalMediaCount": 0,
          "TotalResearchCount": 2,
          "TotalRnsCount": 0
        },
        {
          "CompanyName": "CRISPR Therapeutics AG",
          "CompanyUrl": "https://www.research-tree.com/companies/usa/health/crispr-therapeutics-ag/CRSP/NAS",
          "CurrentPrice": 0.0,
          "CustomSectors": [],
          "Id": "H8NDNT-R",
          "InternalId": "fc120d7d-2c9d-49b7-a018-4dcf8d5f9c40",
          "Isin": "CH0334081137",
          "LastDateContentWasAdded": "0001-01-01T00:00:00",
          "LastDateContentWasChanged": "0001-01-01T00:00:00",
          "LastDateContentWasRemoved": "0001-01-01T00:00:00",
          "LatestRating": null,
          "LatestRatingDate": "0001-01-01T00:00:00",
          "Location": "Not Set",
          "MarketCap": 0.0,
          "PriceChg": 0.0,
          "PriceChgPercent": 0.0,
          "Sector": "Biotechnology",
          "Ticker": "CRSP:NAS",
          "TIDM": "CRSP",
          "BBTicker": "CRSP",
          "AltTicker": "CRSP",
          "AltExchange": "US",
          "Exchange": "NAS",
          "TotalBlogCount": 0,
          "TotalEventCount": 0,
          "TotalMediaCount": 0,
          "TotalResearchCount": 1,
          "TotalRnsCount": 0
        },
        {
          "CompanyName": "MaxCyte, Inc.",
          "CompanyUrl": "https://www.research-tree.com/companies/usa/health/maxcyte-inc-/MXCT/NAS",
          "CurrentPrice": 0.0,
          "CustomSectors": [],
          "Id": "M1KB0H-R",
          "InternalId": "834b40e9-3703-4f94-b1b3-91442251528e",
          "Isin": "M1KB0H-R    ",
          "LastDateContentWasAdded": "0001-01-01T00:00:00",
          "LastDateContentWasChanged": "0001-01-01T00:00:00",
          "LastDateContentWasRemoved": "0001-01-01T00:00:00",
          "LatestRating": null,
          "LatestRatingDate": "0001-01-01T00:00:00",
          "Location": "Not Set",
          "MarketCap": 0.0,
          "PriceChg": 0.0,
          "PriceChgPercent": 0.0,
          "Sector": "Biotechnology",
          "Ticker": "MXCT:NAS",
          "TIDM": "MXCT",
          "BBTicker": "MXCT",
          "AltTicker": "MXCT",
          "AltExchange": "US",
          "Exchange": "NAS",
          "TotalBlogCount": 0,
          "TotalEventCount": 0,
          "TotalMediaCount": 1,
          "TotalResearchCount": 3,
          "TotalRnsCount": 0
        },
        {
          "CompanyName": "Maxcyte",
          "CompanyUrl": "https://www.research-tree.com/companies/uk/health/maxcyte/MXCS/LON",
          "CurrentPrice": 0.0,
          "CustomSectors": [],
          "Id": "USU575801175",
          "InternalId": "3f2991be-13ec-436f-9fee-f0ccb9f00c02",
          "Isin": "USU575801175",
          "LastDateContentWasAdded": "0001-01-01T00:00:00",
          "LastDateContentWasChanged": "0001-01-01T00:00:00",
          "LastDateContentWasRemoved": "0001-01-01T00:00:00",
          "LatestRating": null,
          "LatestRatingDate": "0001-01-01T00:00:00",
          "Location": "Not Set",
          "MarketCap": 0.0,
          "PriceChg": 0.0,
          "PriceChgPercent": 0.0,
          "Sector": "Biotechnology",
          "Ticker": "MXCS:LON",
          "TIDM": "MXCS",
          "BBTicker": "MXCS",
          "AltTicker": "MXCS",
          "AltExchange": "LN",
          "Exchange": "LON",
          "TotalBlogCount": 0,
          "TotalEventCount": 1,
          "TotalMediaCount": 0,
          "TotalResearchCount": 1,
          "TotalRnsCount": 0
        }
      ],
      "Location": "Not Set",
      "CanDirectDownload": false,
      "LoggedInUserHasAccess": true,
      "IsPremiumOnly": false,
      "OnlyAvailableToPayingClients": false,
      "DirectDownloadUrl": null,
      "DirectDownloadViewerUrl": null,
      "PartnerViewerUrl": null,
      "PublishedDate": "2022-09-29T08:10:41.1",
      "LastModifiedDateTime": "2022-09-29T08:10:40.13"
    }
  ],
  "Message": null,
  "TotalItems": 1
}